Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:true

person:goldea01

Total Results:

88

Journal of cellular biochemistry. Supplement. 1988:100(12 PART A):131-8.DOI:

INHIBITION OF A431 CELL GROWTH BY BETA-TGF AND EGF

GOLDENBERG A; CASTAGNOLA J; CRONIN M; MACLEOD C; MENDELSOHN J
BIOSIS:PREV198835054604
ISSN: 0733-1959
CID: 92750
Proceedings (American Association for Cancer Research). 1988:29(13 PART B):436-1625.DOI:

EGF RECEPTOR EGFR OVEREXPRESSION AND TUMOR LOCALIZATION WITH INDIUM-LABELED ANTI-EGFR MAB [Meeting Abstract]

GOLDENBERG A; MASUI H; MENDELSOHN J
BIOSIS:PREV198835039950
ISSN: 0197-016x
CID: 92749
Journal of cellular biochemistry. 1987:26-26.DOI:

VARYING EFFECTS OF EGF UPON PROLIFERATION OF CULTURED A431 CELLS [Meeting Abstract]

GOLDENBERG, A; SUNADA, H; PEACOCK, J; CASTAGNOLA, J; MENDELSOHN, J
ISI:A1987G108200054
ISSN: 0730-2312
CID: 92742
Transactions of the Association of American Physicians. 1987:100:173-8.DOI:

Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway

Mendelsohn, J; Masui, H; Goldenberg, A
Monoclonal antibodies which bind to the EGF receptor have the capacity to inhibit EGF-induced effects upon proliferation and biochemical functions in cultured human cells. Some EGF receptor-bearing tumor cells are prevented from growth by treatment with antireceptor antibody. Evidence is presented which suggests that antibody-mediated antiproliferative activity may result from effects upon growth factor-dependent processes in the receptor-bearing cells
PMID: 3502661
ISSN: 0066-9458
CID: 97084
Proceedings (American Association for Cancer Research). 1987:28:54-54.DOI:

EGF-DEPENDENT GROWTH OF A431 CELLS IN COLLAGEN GEL CULTURE [Meeting Abstract]

GOLDENBERG, A; SUNADA, H; MENDELSOHN, J
ISI:A1987G979900214
ISSN: 0197-016x
CID: 4848482
Proceedings (American Society of Clinical Oncology). 1987:6.DOI:

Survival of patients with advanced gastic cancer treated with phase II (PII) agents as first line therapy [Meeting Abstract]

Goldenberg A; Kelsen D; Lipperman R; Chang E; Magill G; Dougherty J
ORIGINAL:0006502
ISSN: 0736-7589
CID: 92763
Prostaglandins. 1977:13(1):25-31.DOI: 10.1016/0090-6980(77)90039-9

Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis

Zurier, R B; Doty, J; Goldenberg, A
The cyclic AMP response to prostaglandin E1 (PGE1) was studied in peripheral blood (PB) and synovial fluid (SF) mononuclear cells from patients with rheumatoid arthritis (RA). The PGE1 induced accumulation of cyclic AMP was consistently (7 of 8 patients) less in cell suspensions derived from SF than in suspensions of equivalent numbers of mononuclear cells obtained simultaneously from PB. The high PB/SF cyclic AMP ratio was seen most clearly at the lowest concentration (10(-6)M) of PGE1 tested. There was no correlation between the patients' therapy and cyclic AMP response to PGE1. The high PB/SF cyclic AMP ratio was not accounted for by the presence of platelets in PB cell suspensions
PMID: 190647
ISSN: 0090-6980
CID: 142272
Arthritis & rheumatism. 1974:17(6):1007-15.DOI: 10.1002/art.1780170613

Clinical features and serologic abnormalities in juvenile rheumatoid arthritis

Rudnicki, R D; Ruderman, M; Scull, E; Goldenberg, A; Rothfield, N
PMID: 4215425
ISSN: 0004-3591
CID: 1383712